This article is more than 5 years old. Information may no longer be current.
Daily disposable contact lenses safer, easier
Click Here to Manage Email Alerts
Researchers reported that corneal infiltrative events were significantly lower with daily disposable contact lens wear compared to reusable soft contact lens wear in a study recently published in Investigative Ophthalmology and Vision Science.
Chalmers and colleagues enrolled 1,171 participants from 37 sites with 83 clinicians into the TEMPO Registry. They reported that 965 participants completed the study.
Researchers tracked patients during 1 year as they wore 1 Day Acuvue TruEye (Johnson & Johnson Vision Care), a silicone hydrogel daily disposable (SiHyDD), or 1 Day Acuvue Moist (J&J), a hydrogel daily disposable (HyDD).
Results showed that, in 960.3 years of contact lens wear, 610 SiHyDD participants experienced eight adverse events with office visits, eight without office visits and four unrelated. Of these adverse events, two were corneal infiltrative events (CIEs). Additionally, 570 HyDD participants experienced three adverse events with office visits, five without office visits and one unrelated. Of these adverse events, none were CIEs.
Researchers noted that the rates of CIE in the SiHyDD and HyDD wearers was both significantly lower than the lowest estimate from previous studies as well as rates reported with reusable soft contact lens wear.
"This postmarket surveillance registry provides encouraging and important real-life information on the safety outcomes with ordinary use of these DD lenses," the authors concluded. "The low rate of symptomatic adverse events at 0.9%/y, and symptomatic CIEs in particular at 0.2%/y, should fuel wider use of these lens types in order to make the wearing experience safer and easier for the lens wearer and eye care practitioner alike. This could also result in a reduction of health-related spending due to soft contact lens use. In particular, these results point to active prescribing for lens wearers 16 to 25 years and older than 50 years who are in higher-risk groups due to their demographics." – by Chelsea Frajerman
Disclosures: Chalmers reports affiliations with Johnson & Johnson Vision Care Inc., Alcon Research Ltd., and CooperVision, Inc. Please see the full study for a list of all other authors' relevant financial disclosures.
Click Here to Manage Email Alerts